Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Olivier Mir



Gustave Roussy Cancer Institute
University of Paris-Sud

Olivier Mir, MD, PhD, MPH is a medical oncologist and clinical pharmacologist in Gustave Roussy Cancer Institute, University of Paris-Sud.

Dr. Mir trained as a medical oncologist and clinical pharmacologist at University Paris Descartes, and obtained the Silver medal (highest degree) from Paris Medical School in 2009.

Dr. Mir is currently member of Breast and Sarcoma Groups at Gustave Roussy Cancer Institute in Paris, and is an active member of the French Sarcoma Group (GSF-GETO), ASCO, ESMO, and EORTC Soft Tissue and Bone Sarcoma Group.

His main research interests are: sarcoma/GIST, anti-VEGF agents, early drug development, and geriatric oncology. He is also involved in translational research aspects related to precision medicine and pharmacokinetics notably in sarcoma/GIST. Dr. Mir has contributed to over 140 peer-reviewed medical publications.

Since 2014 he has been Associate Editor of ESMO Annals of Oncology Committee. 

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings